Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00657 |
| Species: | Homo sapiens |
| Position : | chr8:128972341-128973219 |
| Year: | 2024 |
| Title: | Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | chronic myeloid leukemia |
| PMID: | 38760567 |
| MONDO: | MONDO:0011998 |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | K562 |
| CVCL ID: | CVCL_0004 |
| Cell Type: | chronic myeloid leukemia cell |
| Cell Ontology ID: | CL:0001054 |
| Experiment Type: | Functional perturbation assay |
| High Throughput Method: | RNA-seq |
| Low Throughput Method: | CRISPRi, Flow Cytometry, qRT-PCR |
| Target gene : | MYC |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00167 | chr8:128750000-129000000 | Breast | breast carcinoma cell | breast carcinoma |